Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 41

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 41
---
 Lion Purchase Agreement, and (ii) 30,000,000 Class A Ordinary Shares underlying the Remaining Additional notes, the Exchange Notes, the Warrants, and the New CB Initial Note.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Ordinary Shares after this offering                    |     | Up to 52,152,702 Ordinary Shares, consisting of 52,148,596 Class A Ordinary Shares and 4,106 Class B Ordinary Shares.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Use of proceeds                                        |     | All of the securities offered by the Selling Securityholders pursuant to this prospectus will be sold by the Selling Securityholders for their respective accounts. We will not receive any of the proceeds from such sales. However, we may receive up to $500,000,000 in gross proceeds under the White Lion Purchase Agreement from sales of Class A Ordinary Shares that we may elect to make to White Lion pursuant to the White Lion Purchase Agreement. In addition, we may receive proceeds from the conversion of the Additional Notes, the Exchange Notes, the Warrants and the New CB Initial Note. All proceeds from the conversion of the Additional Notes, Exchange Notes, Warrants, New CB Initial Note, and the sales of Class A Ordinary Shares to White Lion will be used for working capital and other general corporate purposes. |
| Risk factors                                           |     | You should read the “Risk Factors” section starting on page 25 of this prospectus for a discussion of factors to consider carefully before deciding to invest in our securities.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Nasdaq symbol                                          |     | “NIVF” (Class A Ordinary Shares); “NIVFW” (Warrants to purchase Class A Ordinary Shares).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

The number of Ordinary Shares issued and outstanding is 2,152,702 as of August 21, 2025. No new Class A Ordinary Shares will be issued by us under this offering.

<div align='center'>24

RISK FACTORS</div>

Investing in our Class A Ordinary
Shares involves a high degree of risk. You should carefully consider the risks in this prospectus, the risk factors described under the
caption “Risk Factors” in any applicable prospectus supplement and any risk factors set forth in our other filings
with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, before
making a decision about investing in our Class